E1210 is a new antifungal compound with a novel mechanism of action and broad spectrum of antifungal activity. We investigated the in vitro antifungal activities of E1210 compared to those of fluconazole, itraconazole, voriconazole, amphotericin B, and micafungin against clinical fungal isolates. E1210 showed potent activities against most Candida spp. (MIC 90 of <0.008 to 0.06 g/ml), except for Candida krusei (MICs of 2 to >32 g/ml). E1210 showed equally potent activities against fluconazole-resistant and fluconazole-susceptible Candida strains. E1210 also had potent activities against various filamentous fungi, including Aspergillus fumigatus (MIC 90 of 0.13 g/ml). E1210 was also active against Fusarium solani and some black molds. Of note, E1210 showed the greatest activities against Pseudallescheria boydii (MICs of 0.03 to 0.13 g/ml), Scedosporium prolificans (MIC of 0.03 g/ml), and Paecilomyces lilacinus (MICs of 0.06 g/ml) among the compounds tested. The antifungal action of E1210 was fungistatic, but E1210 showed no trailing growth of Candida albicans, which has often been observed with fluconazole. In a cytotoxicity assay using human HK-2 cells, E1210 showed toxicity as low as that of fluconazole. Based on these results, E1210 is likely to be a promising antifungal agent for the treatment of invasive fungal infections.

The Fermi Large Area Telescope (LAT) has opened the way for comparative studies of cosmic rays (CRs) and high-energy objects in the Milky Way (MW) and in other, external, star-forming galaxies. Using 2 yr of observations with the Fermi LAT, Local Group galaxy M31 was detected as a marginally extended gamma-ray source, while only an upper limit has been derived for the other nearby galaxy M33. We revisited the gamma-ray emission in the direction of M31 and M33 using more than 7 yr of LAT Pass 8 data in the energy range -0.1 100 GeV, presenting detailed morphological and spectral analyses. M33 remains undetected, and we computed an upper limit of´---2.0 10 erg cm s 12 2 1 on the -0.1 100 GeV energy flux (95% confidence level). This revised upper limit remains consistent with the observed correlation between gamma-ray luminosity and star formation rate tracers and implies an average CR density in M33 that is at most half of that of the MW. M31 is detected with a significance of nearly s 10 . Its spectrum is consistent with a power law with photon index G =  + 2.4 0.1 stat syst and a -0.1 100 GeV energy flux of ( ) + ---5.6 0.6 10 erg cm s stat syst 12 21 . M31 is detected to be extended with a s 4 significance. The spatial distribution of the emission is consistent with a uniform-brightness disk with a radius of 0°. 4 and no offset from the center of the galaxy, but nonuniform intensity distributions cannot be excluded. The flux from M31 appears confined to the inner regions of the galaxy and does not fill the disk of the galaxy or extend far from it. The gamma-ray signal is not correlated with regions rich in gas or star formation activity, which suggests that the emission is not interstellar in origin, unless the energetic particles radiating in gamma rays do not originate in recent star formation. Alternative and nonexclusive interpretations are that the emission results from a population of millisecond pulsars dispersed in the bulge and disk of M31 by disrupted globular clusters or from the decay or annihilation of dark matter particles, similar to what has been proposed to account for the so-called Galactic center excess found in Fermi-LAT observations of the MW.

E1210 is a first-in-class, broad-spectrum antifungal with a novel mechanism of action-inhibition of fungal glycosylphosphatidylinositol biosynthesis. In this study, the efficacies of E1210 and reference antifungals were evaluated in murine models of oropharyngeal and disseminated candidiasis, pulmonary aspergillosis, and disseminated fusariosis. Oral E1210 demonstrated dose-dependent efficacy in infections caused by Candida species, Aspergillus spp., and Fusarium solani. In the treatment of oropharyngeal candidiasis, E1210 and fluconazole each caused a significantly greater reduction in the number of oral CFU than the control treatment (P < 0.05). In the disseminated candidiasis model, mice treated with E1210, fluconazole, caspofungin, or liposomal amphotericin B showed significantly higher survival rates than the control mice (P < 0.05). E1210 was also highly effective in treating disseminated candidiasis caused by azole-resistant Candida albicans or Candida tropicalis. A 24-h delay in treatment onset minimally affected the efficacy outcome of E1210 in the treatment of disseminated candidiasis. In the Aspergillus flavus pulmonary aspergillosis model, mice treated with E1210, voriconazole, or caspofungin showed significantly higher survival rates than the control mice (P < 0.05). E1210 was also effective in the treatment of Aspergillus fumigatus pulmonary aspergillosis. In contrast to many antifungals, E1210 was also effective against disseminated fusariosis caused by F. solani. In conclusion, E1210 demonstrated consistent efficacy in murine models of oropharyngeal and disseminated candidiasis, pulmonary aspergillosis, and disseminated fusariosis. These data suggest that further studies to determine E1210's potential for the treatment of disseminated fungal infections are indicated.

No abstract

Microtubule-targeting agents (MTA) have been investigated for many years as payloads for antibody-drug conjugates (ADC). In many cases, these ADCs have shown limited benefits due to lack of efficacy or significant toxicity, which has spurred continued investigation into novel MTA payloads for next-generation ADCs. In this study, we have developed ADCs using the MTA eribulin, a derivative of the macrocyclic polyether natural product halichondrin B, as a payload. Eribulin ADCs demonstrated in vitro potency and specificity using various linkers and two different conjugation approaches. MORAb-202 is an investigational agent that consists of the humanized anti-human folate receptor alpha (FRA) antibody farletuzumab conjugated via reduced interchain disulfide bonds to maleimido-PEG 2 -valine-citrulline-p-aminobenzylcarbamyl-eribulin at a drug-to-antibody ratio of 4.0. MORAb-202 displayed preferable biophysical properties and broad potency across a number of FRA-positive tumor cell lines as well as demonstrated improved specificity in vitro compared with farletuzumab conjugated with a number of other MTA payloads, including MMAE, MMAF, and the reducible maytansine linker-payload sulfo-SPDB-DM4. A single-dose administration of MORAb-202 in FRA-positive human tumor cell line xenograft and patient-derived tumor xenograft models elicited a robust and durable antitumor response. These data support further investigation of MORAb-202 as a potential new treatment modality for FRA-positive cancers, using the novel MTA eribulin as a payload. Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis):

No abstract

A 2D computational model of the mixing of multiple metal vapours into a helium arc in gas tungsten arc welding of stainless steel is presented. The combined diffusion coefficient method, extended to three-gas mixtures, is used to treat helium–chromium–iron and helium–manganese–iron plasmas. It is found that all metal vapours penetrate to the arc centre and reach the cathode, with iron vapour confined near the cathode tip, while chromium and manganese vapours accumulate about 1.5 mm above the tip. The predicted distributions of chromium, manganese and iron show reasonable agreement with published photographic images and radial distributions of atomic line emission intensities. The results are also consistent with published measurements of the deposition of the metals on the cathode surface. A detailed examination of the influence of the different diffusion coefficients, net emission coefficients and vapour pressures of the metals on the metal vapour transport in the arc plasma is presented. It is shown that cataphoresis (diffusion due to applied electric fields) leads to the penetration of the metal vapours into the arc. The different distribution of iron vapour from those of chromium and manganese vapours near the cathode is strongly influenced by the lower ordinary diffusion coefficients of iron at low temperatures. Radiative emission is found to be important since it leads to cooling of the arc, which decreases the influence of cataphoresis. The vapour pressure only influences the concentration of the metal vapour close to the workpiece. Results for the two-gas helium–chromium and helium–iron systems are compared to those for the three-gas helium–chromium–iron system. It is shown that it is important to consider the different metal vapours simultaneously to obtain an accurate calculation of the metal vapour and arc temperature distributions.

No abstract